Long-Term Liabilities: The sum of all non-current liabilities.
Beam Therapeutics Inc. (BEAM) had Long-Term Liabilities of $162.52M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$9.70M |
|
$-112.73M |
|
-- |
|
$9.70M |
|
$136.51M |
|
$-126.81M |
|
$14.08M |
|
$-112.73M |
|
$-112.73M |
|
$-112.73M |
|
$-112.73M |
|
$-112.73M |
|
$-112.73M |
|
$-126.81M |
|
$-125.48M |
|
102.57M |
|
102.57M |
|
$-1.10 |
|
$-1.10 |
|
| Balance Sheet Financials | |
$1.10B |
|
$108.29M |
|
$212.53M |
|
$1.31B |
|
$182.56M |
|
-- |
|
|
Long-Term Liabilities |
$162.52M |
$345.08M |
|
$966.00M |
|
$966.00M |
|
$966.00M |
|
101.36M |
|
| Cash Flow Statement Financials | |
$-261.81M |
|
$-229.84M |
|
$476.16M |
|
$290.11M |
|
$274.62M |
|
$-15.49M |
|
$73.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1307.60% |
|
-1307.60% |
|
-- |
|
-1162.38% |
|
-1162.38% |
|
$-273.02M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-11.67% |
|
-11.67% |
|
-8.60% |
|
-11.67% |
|
$9.53 |
|
$-2.66 |
|
$-2.55 |
|